Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current ...

An early clinical trial headed by researchers at Keio University School of Medicine has shown that the Parkinson’s disease drug ropinirole is safe to use in patients with the fatal motor neuron ...

Ropinirole (as HCl) 2mg, 4mg, 6mg, 8mg, 12mg; ext-rel tabs. Swallow whole. Initially 2mg once daily for 1–2 weeks, then increase by 2mg/day at ≥1-week intervals up to max 24mg/day (for advanced ...

Ropinirole belongs to a class of drugs known as a non-ergoline dopamine agonist used to treat symptoms of Parkinson's disease. This product will be marketed and sold under the Elite Laboratories label ...

ALS is a neurodegenerative disease with a median survival time of approximately 2 years. Muscle weakness eventually leads to respiratory failure and death. Only two drugs have been approved by the US ...

A 16-year-old girl underwent a sleep study for snoring and fatigue. The sleep specialist diagnosed periodic limb movement disorder and recommended ropinirole (Requip). Is this agent safe for a ...

Researchers tested the safety and efficacy of ropinirole in ALS patients in an early-phase clinical trial paired with stem cell research to explore ropinirole's mechanism of action. Credit must be ...